Posts Tagged ‘sucampo’



Sucampo Receives Marketing Authorization For Amitiza(R) In Switzerland For Treatment Of Chronic Idiopathic Constipation

Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC). (Source: GastroIntestinal News From Medical News Today) Go to Source Full story

Sucampo Announces Lubiprostone Data Presented At GASTRO 2009 UEGF/WCOG

Sucampo Pharma Europe, Ltd., and Sucampo Pharma Americas, Inc., subsidiaries of Sucampo Pharmaceuticals, Inc. Go to Source Full story

Amitiza(R) For Treatment Of Chronic Idiopathic Constipation

Amitiza(R) For Treatment Of Chronic Idiopathic Constipation
Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC). This is the first European regulatory approval for Sucampo and Amitiza is the ... Full story


Copyright © 2010 Procto Med. All rights reserved.